On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Blood hemostasis
- Activation of procoagulant factors by injury
- Anticoagulant factors
- The role of antithrombin and heparan sulfate
- Antithrombin
- Inherited deficiencies of antithrombin
- Mutations causing antithrombin dysfunction
- Serpins: proteolytic enzymes regulators
- Serpins characteristics
- Lock-and-key vs.serpin type protease inhibitors
- Serpin type protease inhibitors structure
- Inhibition mechanism through antithrombin activity
- Heparin/heparan sulfate structure
- Activation of antithrombin
- X-ray structure of the antithrombin-heparin complex
- Close-up of the heparin binding site of antithrombin
- Antithrombin "hotspots" binding heparin
- Heparin binds antithrombin in a two-step process
- Antithrombin hotspots contribute to heparin binding
- Effect of saccharides: antithrombin-heparin affinity
- The induced-conformational change binding
- Pre-equilibrium binding mechanism
- Allosteric activation of antithrombin by heparin
- Effect of heparin on antithrombin reactivity
- Activation mechanisms of antithrombin by heparin
- The bridging mechanism
- The conformational activation mechanism (1)
- The conformational activation mechanism (2)
- Hypothesis: reactivity enhancment by reactive loop
- Results of the hypothesis tested
- Modified conformational activation mechanism
- Mapping the antithrombin exosite (1)
- Mapping the antithrombin exosite (2)
- Localization of the exosite of antithrombin
- Two residues mutants affect antithrombin reactivity
- Antithrombin/heparin/FXa complexes structures
- Heparin activation of antithrombin: summary
- Conserved residues in the reactive loop sequences
- Limited reactivity of serpin by the AT reactive loop
- Molecular basis for antithrombin selective reactivity
- Negative features of heparin anticoagulant thepray
- Reference (1)
- Reference (2)
- Reference (3)
Topics Covered
- Antithrombin and hemostasis
- Dysfunctional antithrombins and thrombophilia
- Protease regulation by serpins
- Heparin requirement for antithrombin function
- Structural determinants of heparin binding to antithrombin
- Heparin-induced conformational changes in antithrombin
- Heparin as an allosteric activator of antithrombin
- Bridging and conformational change mechanisms of heparin activation of antithrombin
- Structural basis of conformational activation
- Role of exosites in conformational activation
- Role of the reactive loop in antithrombin anticoagulant function
- Implications for improved heparin anticoagulants
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Olson, S. (2007, October 1). Regulation of blood coagulation by the serpin, antithrombin [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 15, 2025, from https://doi.org/10.69645/VLVT7240.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Steve Olson has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.